Loading chart…
PRE-MARKET
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients.
Alembic Pharmaceuticals Limited (APLLTD) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The APLLTD share price is ₹1,010.00 (+13.48% today), with a market capitalisation of ₹199B and a price-to-earnings (P/E) ratio of 23.5. MarketRipple tracks the APLLTD investment thesis, the ripple-chain impact of market events on Alembic Pharmaceuticals Limited, and the Healthcare sector outlook.
Open
₹968.00
High
₹1,039.00
Low
₹966.15
Prev. Close
₹890.00
52W High
₹1,039.00
52W Low
₹635.80
Day range
₹966.15–₹1,039.00
52-week range
₹635.80–₹1,039.00
Volume
229K
P/E
23.5
ROE
14.9%
D/E
0.25
Margin
9.9%
Alembic Pharmaceuticals Limited (NSE: APLLTD) is currently trading at ₹1,010.00 (+13.48%).
Alembic Pharmaceuticals Limited's market capitalization is ₹199B.
Alembic Pharmaceuticals Limited's price-to-earnings (P/E) ratio is 23.5.
Alembic Pharmaceuticals Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Alembic Pharmaceuticals Limited currently reads positive, based on 10 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.